Key facts
- This page summarizes Jacqueline B. Kosecoff's Form 4 filing for STERIS plc (STE).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 15 May 2024, 16:39.
Jacqueline B. Kosecoff - 13 May 2024 Form 4 Insider Report for STERIS plc (STE)
- Reporting relationship
- Director
- Issuer ticker
- STE
- Reported as of
- 13 May 2024
- Net transaction value
- -$825,120
- SEC form
- 4
- Accepted by SEC
- 15 May 2024, 16:39:23 UTC
- Prior SEC filing
- 15 Mar 2024
- Next SEC filing
- 24 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ronald E. Snyder, Authorized Representative under Power of Attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jacqueline B. Kosecoff filed Form 4 for STERIS plc (STE) on 15 May 2024.
Change
- Previous filing in this sequence was filed on 15 Mar 2024.
- Current net transaction value: -$825,120.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
STE
transaction
Ordinary Shares
Options Exercise
- Transaction value
- $236,214
- Shares
- +4,584
- Change %
- Price
- $51.53
- Shares after
- 4,584
- Date
- 13 May 2024
- Ownership
- Direct
STE
transaction
Ordinary Shares
Sale
- Transaction value
- $1,061,334
- Shares
- -4,584
- Change %
- -100%
- Price
- $231.53
- Shares after
- 0
- Date
- 13 May 2024
- Ownership
- Direct
- Footnotes
- F1
STE
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 26,639
- Date
- 13 May 2024
- Ownership
- See Footnote Below
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
STE
transaction
Derivative
Director Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -4,584
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 13 May 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 4,584
- Exercise price
- $51.53
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Price reflects a weighted average sale price for multiple transactions ranging from $231.3719 to $231.74 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Footnote F2
These ordinary shares are held in a revocable family trust of the Reporting Person and the Reporting Person's spouse, as Co-Trustees.
Footnote F3
This option to purchase 4,584 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,584 ordinary shares for $51.53 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.